Transcription of Establishing and Applying Critical Quality Attributes ...
{{id}} {{{paragraph}}}
1 ISCT Liaison Meeting October 19, 2016 Tom Finn, Product Reviewer Office of Tissues and Advanced Therapies FDA/CBER Establishing and Applying Critical Quality Attributes During the Product Development Lifecycle 2 Topics Product terminology CQA and CPP and how they are developed and used during the product lifecycle Considerations for demonstrating product comparability after a manufacturing change 3 A CQA is a physical, chemical, biological, or microbiological property or characteristic that should be within an appropriate limit, range, or distribution to ensure the desired product Quality .
www.fda.gov 1 ISCT Liaison Meeting October 19, 2016 Tom Finn, Ph.D. Product Reviewer Office of Tissues and Advanced Therapies FDA/CBER Establishing and Applying Critical
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}